Blog

Understanding Opsoclonus-Myoclonus Syndrome (OMS): A Comprehensive Guide

Jun 14 2023

9 min read

Share this post:

Opsoclonus-Myoclonus Syndrome (OMS), also known as Dancing Eye Syndrome, is a rare neurological disorder characterized by erratic eye movements (opsoclonus) and sudden, brief muscle contractions (myoclonus). This complex syndrome primarily affects children but can manifest in adults as well.

In this comprehensive guide, we delve into the symptoms, potential causes, diagnosis, and available treatments for OMS to provide a better understanding of this rare condition.

Symptoms of Opsoclonus-Myoclonus Syndrome:

Opsoclonus and myoclonus are the hallmark symptoms of OMS, accompanied by various other neurological manifestations, including:

Opsoclonus: Involuntary, rapid, and irregular eye movements occurring in all directions, often accompanied by nystagmus, making it challenging to maintain visual stability.
Myoclonus: Sudden, brief muscle contractions affecting limbs, trunk, and face, which can be spontaneous or triggered by external stimuli.
Ataxia: Uncoordinated movements, balance issues, and motor control difficulties leading to an unsteady gait and fine motor skill problems.
Behavioral and Cognitive Changes: These can encompass irritability, mood swings, language difficulties, attention deficits, memory problems, and, in some cases, developmental regression.
Sleep Disturbances: Individuals with OMS often experience insomnia, excessive daytime sleepiness, and nightmares.

Causes and Pathophysiology

The precise cause of OMS remains unknown, although it is thought to be associated with autoimmune mechanisms triggered by underlying infections or neuroblastomas (nerve tissue tumors). OMS can also manifest as a paraneoplastic syndrome, where the immune system mistakenly targets normal cells in response to cancer.

Evidence of antibodies in the blood and cerebrospinal fluid, including anti-Ri and anti-Hu antibodies, supports the role of the immune system in OMS. However, not all cases display detectable antibodies, suggesting potential additional contributing factors.

Diagnosis:

Diagnosing OMS can be challenging due to its rarity and symptom overlap with other neurological conditions. A thorough evaluation is essential to rule out alternative causes of opsoclonus, myoclonus, and ataxia. Diagnostic procedures may include blood tests, imaging studies like MRI, and lumbar punctures to examine cerebrospinal fluid.

Treatment Options:

OMS treatment aims to manage symptoms and address underlying causes if identified. It typically involves a multidisciplinary approach with input from neurologists, pediatricians, oncologists (when tumors are present), and other healthcare professionals.

Treatment options include:

Immunotherapy: Corticosteroids, intravenous immunoglobulin (IVIG), and plasmapheresis are common immunotherapies employed to modulate the immune response and reduce symptom severity by suppressing abnormal immune activity.
Tumor Management: In cases where OMS is linked to an underlying neuroblastoma or another tumor, appropriate tumor management is essential.

Conclusion

Opsoclonus-Myoclonus Syndrome is a complex neurological disorder characterized by erratic eye movements, muscle contractions, and various neurological manifestations. While the exact cause remains uncertain, evidence suggests an autoimmune component, often associated with infections or tumors.

Timely diagnosis and a multidisciplinary treatment approach, including immunotherapy and tumor management when necessary, are crucial in providing the best possible outcomes for individuals affected by OMS.

About Rang Technologies

Rang Technologies, based in New Jersey, has dedicated over a decade to delivering innovative staffing solutions and the best talent to help businesses of all sizes unlock the full potential of the latest technologies and build high-performing teams to achieve their digital transformation goals.